The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2025 | Advice for community oncologists when diagnosing multiple myeloma
In this video, Marco Talarico, MD, University of Bologna, Bologna, Italy, provides brief advice for community oncologists assessing patients with suspected multiple myeloma (MM). He emphasizes the importance of timely referral to specialists for comprehensive staging using bone marrow analysis and advanced imaging. Dr Talarico highlights that the presence of asymptomatic focal lesions identified by whole-body MRI represents a criterion for initiating treatment. This interview took place at the 11th World Congress on Controversies in Multiple Myeloma (COMy) congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
Baseline assessment through laboratory markers of monoclonal gammopathies remains a standard. However, when there is a suspicion of multiple myeloma, patients have to be sent to multiple myeloma specialists in order to assess a good staging of disease with bone marrow studies and in particular with imaging techniques, as the presence of even asymptomatic focal lesions by whole body MRI currently represents a criterion for treatment initiation...
Baseline assessment through laboratory markers of monoclonal gammopathies remains a standard. However, when there is a suspicion of multiple myeloma, patients have to be sent to multiple myeloma specialists in order to assess a good staging of disease with bone marrow studies and in particular with imaging techniques, as the presence of even asymptomatic focal lesions by whole body MRI currently represents a criterion for treatment initiation. And so I think this is very important when assessing a diagnosis of multiple myeloma.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
